Add like
Add dislike
Add to saved papers

Reactivity of Organoiridium Tungsten Oxide Clusters with Transition Metal Aquo Cations.

Inorganic Chemistry 2024 March 13
Organometallic-polyoxometalate (POM) complexes form a unique class of molecular organometallic oxides characterized by the dynamic behavior of the organometallic cations. Herein, we investigated the reactivity of Cp*Ir-octatungstate clusters (where Cp* represents pentamethylcyclopentadienyl, C5 Me5 - ) with Werner-type transition-metal aquo cations. The addition of Ag+ , Co2+ , Ni2+ , and M3+ (M = Cr, Fe, or In) cations to the aqueous solution of Cp*Ir-octatungstate clusters resulted in the formation of [{Ag(OH2 )2 }2 {Cp*Ir(OH2 )}2 {Cp*IrW3 O12 (OH)}2 (WO2 )2 ] ( 1 ), Co1.5 K0.8 Na0.2 [{ trans -Co(OH2 )2 }{Cp*IrW3 O12 (OH)}2 (WO2 )1.3 { cis -Co(OH2 )2 }0.7 ] ( 2-Co ), Ni0.2 K1.4 Na0.2 [{Ni(OH2 )4 }2 {Cp*IrW3 O12 (OH)}2 (WO2 )1.1 { cis -Ni(OH2 )2 }0.9 ] ( 2-Ni ), and [{M(OH2 )4 }2 {Cp*IrW3 O12 (OH)}2 { cis -M(OH2 )2 }2 ](NO3 )2 (M = Cr, 3-Cr ; Fe, 3-Fe ; or In, 3-In ), respectively. All clusters share the same cubane-type {Cp*IrW3 O12 (OH)}5- building block, representing the first examples of organoiridium-POMs functionalized by transition-metal aquo cations. These compounds are insoluble in water, facilitating the evaluation of their heterogeneous water-oxidation properties. Notably, 2-Co generates the highest catalytic water oxidation current. This work provides a new synthetic method to introduce metal-aquo complexes on an organometallic oxide cluster, producing multimetallic molecules that model the catalytic sites of complex oxides.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app